Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Garmin's (GRMN) Q4 Earnings and Revenues Beat Estimates

10h zacks
Garmin, Ltd. (GRMN - Free Report) is an original equipment manufacturer (OEM) of navigation and communication equipment that incorporate the global positioning system (GPS)-based technology. (5-0)

DISH Network (DISH) Tops Q4 Earnings Misses Revenues

12h zacks
DISH Network Corp. (DISH - Free Report) is a leading satellite TV operator in the U.S. The company provides video services under the DISH brand. In addition, the company provides satellite broadband services, and wireline voice and broadband services under the dishNET brand. DISH Network’s top-line growth may remain under pressure as the company’s failure to strike any deal with wireless operators to deploy a nationwide wireless network has been a major headwind. (3-0)

Is the Options Market Predicting a Spike in Exact Sciences (EXAS) Stock?

12h zacks
Investors in Exact Sciences Corporation (EXAS - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 23rd 2018 $48 Put had some of the highest implied volatility of all equity options today. (29-0)

Why Earnings Season Could Be Great for Exact Sciences (EXAS)

12h zacks
Investors are always looking for stocks that are poised to beat at earnings season and Exact Sciences Corporation (EXAS - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Exact Sciences is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. (29-0)

What's in the Cards for Geron (GERN) This Earnings Season?

2018-02-20 zacks
Geron Corporation (GERN - Free Report) is expected to report fourth-quarter 2017 results on Mar 7. (80-0)

Earnings Preview: Exact Sciences

2018-02-19 seekingalpha
Strong Cologuard test volumes reported by Exact Sciences (EXAS) in the last quarter sent its share soaring to the $60 level. But since December, when the stock failed to continue its uptrend, investors took a breather instead. The company is losing money each quarter but will turn a profit as Cologuard orders grow. The question is: Does Exact Sciences’ future growth justify its 27.5x price/sales ratio? When the company reports results on Feb.

EXAS / EXACT Sciences Corp. / STATE STREET CORP - 3G/A (Passive Investment)

2018-02-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING EXACT SCIENCES CORPORATION (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 30063P105 (CUSIP NUMBER) 12/31/2017 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: (X) RULE 13D-1 (B) ( ) RULE 13D-1 (C) ( ) RULE 13D-1 (D) *THE REMAINDER OF THIS COVER PAG

EXAS / EXACT Sciences Corp. / STATE STREET CORP - 3G/A (Passive Investment)

2018-02-13 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 EXIT FILING EXACT SCIENCES CORPORATION (NAME OF ISSUER) COMMON STOCK (TITLE OF CLASS OF SECURITIES) 30063P105 (CUSIP NUMBER) 12/31/2017 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: (X) RULE 13D-1 (B) ( ) RULE 13D-1 (C) ( ) RULE 13D-1 (D) *THE REMAINDER OF THIS COVER PAG

EXAS / EXACT Sciences Corp. / WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G* (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)*     Exact Sciences Corporation (Name of Issuer)   Common Stock (Title of Class of Securities)   30063P105 (CUSIP Number)   12/31/2017 (Date of Event Which Requires Filing of the Statement)   Check the appropriate box to designate t

EXAS / EXACT Sciences Corp. / WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - SC 13G/A (Passive Investment)

2018-02-13 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G* (Rule 13d-102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)*     Exact Sciences Corporation (Name of Issuer)   Common Stock (Title of Class of Securities)   30063P105 (CUSIP Number)   12/31/2017 (Date of Event Which Requires Filing of the Statement)   Check the appropriate box to designate t

EXAS / EXACT Sciences Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
exactsciencescorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Exact Sciences Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  30063P105     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) R

EXAS / EXACT Sciences Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
exactsciencescorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Exact Sciences Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  30063P105     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) R

EXAS / EXACT Sciences Corp. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G (Passive Investment)

2018-02-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ )* EXACT SCIENCES CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 30063P105 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The rem

EXAS / EXACT Sciences Corp. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G (Passive Investment)

2018-02-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ )* EXACT SCIENCES CORPORATION (Name of Issuer) Common Stock (Title of Class of Securities) 30063P105 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The rem

EXAS / EXACT Sciences Corp. PP

2018-01-31 sec.gov
SEC File No. 812 _______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549   APPLICATION FOR AN ORDER PURSUANT TO SECTION 3(b)(2) OF THE INVESTMENT COMPANY ACT OF 1940 DECLARING THAT EXACT SCIENCES CORPORATION IS NOT AN INVESTMENT COMPANY UNDER THE 1940 ACT IN THE MATTER OF EXACT SCIENCES CORPORATION   Please direct all communications concerning this application to: C. Dirk Peterson K&L Gates LLP 1601 K Street, N.


CUSIP: 30063P105